Why the study?
Optimal management of ACS in elderly patients remains challenging due to clinical peculiarities and scarce specific data, with controversial and incomplete evidence regarding invasive versus conservative strategies.
Does a routine invasive strategy improve clinical outcomes in elderly patients with acute coronary syndrome?
Does a routine invasive strategy improve clinical outcomes in elderly patients with acute coronary syndrome?
In elderly patients with NSTE-ACS, a routine invasive strategy reduces myocardial infarction and the need for subsequent revascularization but does not clearly improve mortality, highlighting the need to incorporate frailty and comorbidity assessments into clinical decision-making.
Answers are grounded in this paper and cite their sources.
Optimal ACS management in elderly remains uncertain with limited data; leaves open need for dedicated trials.
Elderly population constitutes an increasingly larger proportion of patients admitted for acute coronary syndromes (ACS). The optimal management of ACS in these patients is still a challenge due to their clinical peculiarities and the paucity of specific data, and they have been traditionally managed more conservatively mainly based on subjective criteria. In ST-segment elevation acute myocardial infarction urgent reperfusion is the standard of care and there is no upper age limit. In non-ST segment elevation acute myocardial infarction evidence is controversial, incomplete and mainly focused on chronological age. While a strict conservative strategy should be avoided, routine invasive strategy may reduce the occurrence of myocardial infarction and need for revascularization at follow-up with no established benefit in terms of mortality. Clinical characteristics associated with aging, such as comorbidities and frailty, further discriminate patient's risk beyond age. Evidence is scarce, but it suggests that these features may modulate the benefit of invasive strategy in this population. Ongoing trials should clarify the optimal management of ACS based on these parameters.
No takes yet. Share an insight, caveat, or question.
García‐Blas et al. (2019) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: